Sedation vs. Intubation for Endovascular Stroke TreAtment (SIESTA)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
| Condition | Intervention |
|---|---|
| Acute Ischemic Stroke | Procedure: Endovascular recanalisation |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Sedation vs. Intubation for Endovascular Stroke TreAtment |
- National Institutes of Health Stroke Scale (NIHSS) after 24 hours [ Time Frame: 24 hours ]Neurological improvement of NIHSS 24 hours after intervention
- Outcome after 3 month using the modified Rankin Scale (mRS) [ Time Frame: 3 month ]Assessing the neurological outcome after 3 months with the mRS.
- Inpatient-mortality [ Time Frame: Mortality-rate until timepoint of discharge, an expected average of 3 weeks. ]
- Mortality-rate within the first 3 months after intervention. [ Time Frame: First 3 months after intervention ]
- Duration of hospital stay [ Time Frame: Participants will be followed until timepoint of discharge, an expected average of 3 weeks. ]
- Periinterventional complications [ Time Frame: Evaluation of Adverse Events as a Measure of Safety and Tolerability until timepoint of discharge, an expected average of 3 weeks. ]
- Achieved recanalisation grade [ Time Frame: Duration of intervention with an expected average of 2 hours ]Recanalisation status is classified according to the Thrombolysis in Cerebral Infarction classification (TICI).
| Enrollment: | 150 |
| Study Start Date: | April 2014 |
| Study Completion Date: | May 2016 |
| Primary Completion Date: | February 2016 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Intubation
Intubation and invasive mechanical ventilation + endovascular recanalisation
|
Procedure: Endovascular recanalisation
Endovascular recanalisation by mechanical thrombectomy with e.g. stent retriever device, possibly following intravenous thrombolysis within a "bridging concept"
|
|
Experimental: No Intubation
Conscious sedation and non-invasive ventilatory support + endovascular recanalisation
|
Procedure: Endovascular recanalisation
Endovascular recanalisation by mechanical thrombectomy with e.g. stent retriever device, possibly following intravenous thrombolysis within a "bridging concept"
|
Detailed Description:
Early recanalization is an important, if not the most important, factor concerning reconstitution of patients´ health in ischaemic stroke. This is the reason why patients with extended stroke are increasingly subjected to an endovascular stroke therapy (EST).
Matter of ongoing debate is how to sedate these patients during intervention. Some clinicians prefer an intubation due to a reduction of patients´movements and therefore potentially lowering complication rates (injury by catheter, aspiration e.g.).
On the other hand retrospective investigations hypothesize that general anaesthesia is associated with peri-interventional hypotension followed by poorer clinical outcome.
The best anaesthaesiologic management in endovascular stroke therapy to this point of time is not known. The investigators therefore designed this study comparing intubated state with general anaesthesia vs. non-intubated state with conscious sedation during EST, focusing on patients´ outcome.
Eligibility| Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- age ≥18 years
- acute stroke in anterior circulation
- occlusion of carotid artery and/ or middle cerebral artery
- planned mechanical recanalisation
- informed consent from patient or legal representative
Exclusion Criteria:
- age < 18 years
- informed consent not obtainable
- coma
- agitation
- vomiting
- difficult airway management
- additional cerebral hemorrhage
Contacts and LocationsPlease refer to this study by its ClinicalTrials.gov identifier: NCT02126085
| Germany | |
| Department of Neurology, University Hospital Heidelberg | |
| Heidelberg, Baden-Württemberg, Germany, 69120 | |
| Principal Investigator: | Julian Bösel, PD | Department of Neurology, University Hospital Heidelberg |
More Information
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Dr. Silvia Schönenberger, MD, Leading sub-investigator, Principal Investigator: PD Dr. Julian Bösel, MD, University Hospital Heidelberg |
| ClinicalTrials.gov Identifier: | NCT02126085 History of Changes |
| Other Study ID Numbers: |
SIESTA |
| Study First Received: | April 23, 2014 |
| Last Updated: | May 22, 2016 |
Keywords provided by Dr. Silvia Schönenberger, MD, University Hospital Heidelberg:
|
ischemic stroke recanalisation sedation |
Additional relevant MeSH terms:
|
Stroke Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Vascular Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on July 17, 2017


IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
